Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.

A highly significant difference of the ES distributions between these two groups was observed ( p < 0.001).

also in 132,142 other papers

Adjusted for age, gender, and the MMSE score, patients with neurochemically possible AD had about 9 and 4 times larger odds to become demented within 3 and 5 years, respectively, compared to the reference category, although these estimates are statistically weak (borderline significant ( p = 0.048) after 3 years, and insignificant ( p = 0.12) after 5 years).

also in 11,409 other papers